相关实验视频
Updated: May 16, 2025
10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.3K
肌肉炎特异性自身抗体对肌肉炎治疗选择的有用性
Maria Casal-Dominguez1,2, Iago Pinal-Fernández1,2,3, Andrew L Mammen1,2
1Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 50 South Drive, Room 1141, Building 50, MSC 8024, Bethesda, MD 20892, USA.
Current treatment options in rheumatology
|April 4, 2025
概括
在自身免疫性肌肉病 (IMs) 中,肌肉炎特异性自身抗体 (MSA) 与特定的症状和治疗反应有关. 根据MSA配置文件定制疗法可以改善患者的治疗结果并减少不良影响.
科学领域:
- 风湿病学和免疫学
- 神经肌肉疾病 神经肌肉疾病
背景情况:
- 自身免疫性肌肉病变 (IMS) 是一种炎症性肌肉疾病,通常会影响其他器官.
- 分类包括皮肤肌炎,包容体肌炎,免疫媒介性死肌病,多肌炎和重叠肌炎.
- 肌肉炎特异性自身抗体 (MSA) 存在于70%的IM患者中,与临床表型相关.
研究的目的:
- 从肌肉炎特异性自身抗体 (MSA) 的角度审查自身免疫性肌肉病治疗方法.
- 要突出特定的MSA和IM中的临床表现之间的关联.
- 探索MSA资料如何指导治疗决策.
主要方法:
- 关于自身免疫性肌肉病变和肌肉炎特异性自身抗体的研究文献综述.
- 与特定的MSA类型相关的治疗反应的分析.
- 基于自身抗体概况的IM针对性治疗现有证据的综合.
主要成果:
- 特定的MSA与IM中不同的致病途径有关.
- 针对各种MSA患者群体,已经出现了成功的向治疗方法.
- 有证据表明,某些MSA类型对特定的治疗剂反应更好.
结论:
- 考虑MSA组对于优化自身免疫性肌肉病治疗决策至关重要.
- 基于MSA的向疗法有可能提高疗效和降低毒性.
- 对MSA驱动的治疗策略进行进一步的研究是有必要的,以解决耐火病例和不良影响.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.0K
01:15Myasthenia Gravis: Diagnostic Tests
562
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
562